China Medical, Kangzhe Liver Cancer Drug Equal To Placebo In Serious Cases
This article was originally published in PharmAsia News
Executive Summary
A liver-cancer drug co-developed by China Medical System Holdings and Kangzhe Pharmaceutical Research & Development showed in a Phase III trial to be no more effective than a placebo in serious cases.